Online Tumor
Board with a
Molecular Angle

Welcome to Tumor Board Tuesday!

A global, interactive, multi-disciplinary forum that applies emerging molecular insights to advance oncology knowledge and improve clinical care.

@KevinCalsina @yekeduz_emre @TumorBoardTues @Silke_Gillessen @DrChoueiri @neerajaiims @montypal @DrRanaMcKay @umangtalking @APCCC_Lugano @FabioSchutz78 @Prof_Nick_James @drenriquegrande @AtishChoudhury @MikeSerzanMD @PCFnews @AarmstrongDuke @Martin_AngelMD @PGrivasMDPhD @NazliDizman @CParkMD @nataliagandur @zapatalaguadomd @CCR_AACR @umangtalking @neerajaiims

@nataliagandur @yekeduz_emre @TumorBoardTues @Silke_Gillessen @DrChoueiri @neerajaiims @montypal @DrRanaMcKay @umangtalking @APCCC_Lugano @FabioSchutz78 @Prof_Nick_James @drenriquegrande @AtishChoudhury @MikeSerzanMD @PCFnews @AarmstrongDuke @Martin_AngelMD @PGrivasMDPhD @NazliDizman @CParkMD @zapatalaguadomd The other choices are worse outcomes with ARPIs?


@yekeduz_emre @TumorBoardTues @Silke_Gillessen @DrChoueiri @neerajaiims @montypal @DrRanaMcKay @umangtalking @APCCC_Lugano @FabioSchutz78 @Prof_Nick_James @drenriquegrande @AtishChoudhury @MikeSerzanMD @PCFnews @AarmstrongDuke @Martin_AngelMD @PGrivasMDPhD @NazliDizman @CParkMD @nataliagandur @zapatalaguadomd How common is spop alterations and triple negative?, 🤞Hopefully spop will be much more frequent

@Nishant37943085 @KevinCalsina @TumorBoardTues @Silke_Gillessen @DrChoueiri @neerajaiims @montypal @DrRanaMcKay @umangtalking @APCCC_Lugano @FabioSchutz78 @Prof_Nick_James @drenriquegrande @AtishChoudhury @MikeSerzanMD @PCFnews @AarmstrongDuke @Martin_AngelMD @PGrivasMDPhD @NazliDizman @CParkMD @nataliagandur @zapatalaguadomd

Our Team

Michael J. Pishvaian, MD, PhD

TBT Originator; Associate Professor, Dept of Oncology; Dir of GI, Dev Therapeutics, and Clinical Research Programs at NCR Kimmel Cancer Center at Sibley Memorial Hosp Johns Hopkins Uni School of Med

Alison Rothbaum

TBT Program Manager; Autoimmune Patient Advocate; Med Ed Social Media Connoisseur - continually working to bridge communication between clinicians and patients, while building networks for international collaboration.

Johnathan Ebben, MD, PhD

TBT Wrap Up Project Manager; Oncology Fellow; Div of Hematology, Oncology, and Palliative Care at Uni of Wisconsin-Madison; Co-Founder of NanoRed Biotechnology

Community Meetups

TumorBoardTuesday meeting the community

Dr. Johnathan Ebben at ASCO 2023

Dr. Johnathan Ebben & Hannah Hannon at ASCO 2023

Dr. Johnathan Ebben & Dr. Balazs Halmos at ASCO 2023

Dr. Johnathan Ebben & Dr. Rafee Talukder at ASCO 2023

Dr. Eleonora Teplinsky & Dr. Johnathan Ebben at ASCO 2023

Dr. Joao Fogacci & Dr. Michael Pishvaian in Brazil

ASCO 2023

Dr. Johnathan Ebben preparing for ASCO 2023

ASCO 2023

Dr. Petros Grivas & Dr. Rafee Talukder after leading a #TumorBoardTuesday session

Dr. Helene Andrews & Dr. Michael Pishvaian at #TumorBoardTuesday's GI summit

Dr. Pamela Kunz, & Dr. Michael Pishvaian at #TumorBoardTuesday's GI summit

Dr. Johnathan Ebben & Ann ASCO 2023

Dr. Jack West talking about #TumorBoardTuesday & the power of social media

Dr. Michael Pishvaian & Dr. Narjust Florez at fellows retreat

Dra. Rachel Riechelmann, Dr. Joao Fogacci, Dr. Ricardo Carvalho, Dra. Anelisa Coutinho, & Dr. Michael Pishvaian at Brazil symposium

Community Insight (Placeholders ATM)

Want to learn more?

Join Our Mailing List!

Identifiable details you provide will be kept within our team.